Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Hess

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|March 28, 2002
SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directionsRichard B Bankert, Stephen D Hess, Nejat K Egilmez
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsyNicholas D P Cosford, Peter T Meinke, Kenneth A Stauderman, et al.
Archives of Dermatology|November 17, 2010
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeonsAnokhi Jambusaria-Pahlajani, Stephen D Hess, Kenneth A Katz, et al.
Frontiers in Pharmacology|December 16, 2011
The importance of being profiled: improving drug candidate safety and efficacy using ion channel profilingGregory J Kaczorowski, Maria L Garcia, Jacob Bode, et al.
Pediatric Dermatology|August 4, 2010
Ulceroglandular tularemiaJames R Treat, Stephen D Hess, Karin L McGowan, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Cancer Research|May 1, 2002
Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient miceNejat K Egilmez, Stephen D Hess, Fang-An Chen, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
International Journal of Dermatology|July 3, 2009
Subcutaneous Mycobacterium marinum infection in a patient with chronic rheumatoid arthritis receiving immunosuppressive therapyStephen D Hess, Abby S Van Voorhees, Laura M Chang, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2005
CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID miceMichael S Sabel, Stephen D Hess, Nejat K Egilmez, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|March 28, 2002
SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directionsRichard B Bankert, Stephen D Hess, Nejat K Egilmez
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsyNicholas D P Cosford, Peter T Meinke, Kenneth A Stauderman, et al.
Archives of Dermatology|November 17, 2010
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeonsAnokhi Jambusaria-Pahlajani, Stephen D Hess, Kenneth A Katz, et al.
Frontiers in Pharmacology|December 16, 2011
The importance of being profiled: improving drug candidate safety and efficacy using ion channel profilingGregory J Kaczorowski, Maria L Garcia, Jacob Bode, et al.
Pediatric Dermatology|August 4, 2010
Ulceroglandular tularemiaJames R Treat, Stephen D Hess, Karin L McGowan, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Cancer Research|May 1, 2002
Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient miceNejat K Egilmez, Stephen D Hess, Fang-An Chen, et al.
Journal of the American Academy of Dermatology|December 1, 2009
Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaRachel H Gormley, Stephen D Hess, Dipti Anand, et al.
International Journal of Dermatology|July 3, 2009
Subcutaneous Mycobacterium marinum infection in a patient with chronic rheumatoid arthritis receiving immunosuppressive therapyStephen D Hess, Abby S Van Voorhees, Laura M Chang, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2005
CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID miceMichael S Sabel, Stephen D Hess, Nejat K Egilmez, et al.
Pageof 2